Scientists have begun to assess the safety and efficacy of a vaccine designed to provide long-lasting protection against an array of flu viruses, according to the National Institutes of Health (NIH). In the trial, begun at the NIH Clinical Center in Bethesda, Maryland, healthy participants 18 to 50 years old will receive either a licensed… Continue reading Scientists Researching Super Vaccine